Masanobu Takasu
Okayama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Finerenone Improves Albuminuria via MR-TRPC Signaling in Diabetic Kidney Disease.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: January 22, 2026
Endothelial dysfunction accelerates AKI-to-CKD transition by promoting β-catenin activation in macrophages.
Journal: American journal of physiology. Renal physiology
Published: November 21, 2025
The Nonsteroidal Mineralocorticoid Receptor Blocker Esaxerenone reduces glomerular hyperfiltration and albuminuria.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: November 09, 2025
The non-steroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: July 10, 2025
ASK-1 activation exacerbates kidney dysfunction via increment of glomerular permeability and accelerates cellular aging in diabetic kidney disease model mice.
Journal: Scientific reports
Published: August 21, 2024
The Role of Mitochondria in Diabetic Kidney Disease and Potential Therapeutic Targets.
Journal: Kidney international reports
Published: July 30, 2024
Effects of Beraprost on Intestinal Microcirculation and Barrier Function in a Mouse Model of Renal Failure.
Journal: Microcirculation (New York, N.Y. : 1994)
Published: March 06, 2024
A case of pleuroperitoneal communication during long-term steroid therapy for dermatomyositis.
Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
Published: March 23, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026